Page last updated: 2024-09-05

sb 203580 and vx 702

sb 203580 has been researched along with vx 702 in 3 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(vx 702)
Trials
(vx 702)
Recent Studies (post-2010) (vx 702)
3,48941,13722115

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Ayoub, AM; Berndt, N; Carlson, AS; Cui, H; Divakaran, A; Harki, DA; Mishra, NK; Pomerantz, WCK; Schonbrunn, EK; Talluri, SK; Topczewski, JJ; Widen, JC; Zhu, JY1

Other Studies

3 other study(ies) available for sb 203580 and vx 702

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.
    Journal of medicinal chemistry, 2018, 10-25, Volume: 61, Issue:20

    Topics: A549 Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Domains; Protein Kinase Inhibitors; Water

2018